Drugs like Ozempic created a gold rush. These drugmakers want in.

Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion so far, analysts say.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...